Work

Author Correction: Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair

Year: 2025

Type: erratum

Abstract: In this article the author’s name Natalija Ivljanin was incorrectly written as Natalija Ivjanin. The original article has been updated.

Source: Nature Communications

DOI: 10.1038/s41467-025-55864-4

Authors: Jean-Baptiste Huré, Louis Foucault, Litsa Maria Ghayad, Corentine Marie, Nicolas Vachoud, Lucas Baudouin, Rihab Azmani, Natalija Ivljanin, Alvaro Arevalo-Nuevo, Morgane Pigache, Lamia Bouslama-Oueghlani, Julie-Anne Chemelle, Marie-Aimée Dronne, Raphaël Terreux, Bassem Hassan, François Gueyffier, Olivier Raineteau, Carlos Parras

Institutions: Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Institut des Sciences Moléculaires, Pitié-Salpêtrière Hospital, Institut du Cerveau, Lyon 1 Université, Institut Cellule Souche et Cerveau, Laboratoire de Biologie Tissulaire et d'Ingénierie Thérapeutique, Laboratoire de Biométrie et Biologie Evolutive

Language: English

Topic: Neurogenesis and neuroplasticity mechanisms

Subfield: Developmental Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $6,990

Funder: Agence Nationale de la Recherche

Awards: Two FDA-approved drugs promoting oligodendrogenesis in preterm birth brain injury, Pharmacogenomics identification of small bioactive molecules for promoting oligodendrogenesis in a model of neonatal brain injury.

OpenAlex ID: W4406217447

Cites:

Cited by:

Related to: 10